|
Accueil > Actualité
Eli Lilly: positive results in atopic dermatitis
(CercleFinance.com) - Eli Lilly reports that new results show that its EBGLYSS treatment achieved a profound and durable response in patients with moderate to severe atopic dermatitis over three years.
These results will be presented at the annual meeting of the American Academy of Dermatology (AAD), to be held over the weekend of 7-11 March in Orlando. The data show that 50% of patients who responded to treatment at 16 weeks and received a monthly maintenance dose achieved completely clear skin, and 87% almost clear skin (EASI 90). Over 83% did not require concomitant therapies. The data confirm the efficacy of EBGLYSS as a first-line biological treatment. Copyright (c) 2025 CercleFinance.com. All rights reserved. |
17/04/2025 18:18
L'Oréalhausse de 4,4% du chiffre d'affaires trimestriel 17/04/2025 18:12 Accoren négociation exclusive avec Royal Holiday 17/04/2025 18:01 Tarkettléger repli organique des ventes au 1er trimestre 17/04/2025 17:37 RubisUBS Group franchit les 5% du capital 17/04/2025 17:20 Monclerrepli du titre, un broker abaisse sa cible 17/04/2025 17:00 SafranCapital Group Companies sous les 5% des votes Tous les articles sociétés |
